ASX:SPD
ASX:SPDMetals and Mining

3 ASX Penny Stocks With Market Caps Below A$300M

As the Australian market prepares for a modest 0.17% gain, investors are keeping a close eye on global events and their potential impact on local indices. For those willing to explore beyond well-known stocks, penny stocks present intriguing opportunities despite being considered an outdated term. These smaller or newer companies often combine affordability with growth potential, and we'll explore three such stocks that stand out for their financial strength and hidden value.
ASX:CSL
ASX:CSLBiotechs

CSL (ASX:CSL) Secures NICE Approval For Sparsentan Use In NHS England

CSL (ASX:CSL) saw its stock price rise by 3% over the last month, amid important developments and a fluctuating market environment. CSL Vifor's notable progress with the National Institute for Health and Care Excellence recommending sparsentan for primary IgA nephropathy treatment may have provided positive momentum. This significant medical endorsement, alongside CSL's continued engagement with shareholders through meetings, could have added weight to its share performance. Meanwhile,...